Cargando...
Epigallocatechin Gallate in Progressive MS: A Randomized, Placebo-Controlled Trial
OBJECTIVE: To examine whether treatment with epigallocatechin gallate (EGCG) influences progression of brain atrophy, reduces clinical and further radiologic disease activity markers, and is safe in patients with progressive multiple sclerosis (PMS). METHODS: We enrolled 61 patients with primary or...
Guardado en:
| Publicado en: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Autores principales: | , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7954462/ https://ncbi.nlm.nih.gov/pubmed/33622766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000964 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|